The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-4-chlorobenzyl)piperazine-1-carboxylate ID: ALA4517565
Cas Number: 2010154-82-0
PubChem CID: 122530045
Product Number: A607324, Order Now?
Max Phase: Preclinical
Molecular Formula: C21H24ClF6N3O3
Molecular Weight: 515.88
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(Cl)cc2N2CC3CCC(C2)O3)CC1
Standard InChI: InChI=1S/C21H24ClF6N3O3/c22-14-2-1-13(17(9-14)31-11-15-3-4-16(12-31)33-15)10-29-5-7-30(8-6-29)19(32)34-18(20(23,24)25)21(26,27)28/h1-2,9,15-16,18H,3-8,10-12H2
Standard InChI Key: CXSFVTMRWPSLGO-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
13.7650 -18.1580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7639 -18.9855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4787 -19.3983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1951 -18.9849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1923 -18.1544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4769 -17.7453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9103 -19.3963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6240 -18.9827 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3335 -19.3974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0453 -18.9874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0482 -18.1620 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.3332 -17.7485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6154 -18.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7636 -17.7511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4771 -18.1652 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7654 -16.9261 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.1925 -17.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9060 -18.1683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6214 -17.7574 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.9042 -18.9933 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.6164 -18.5789 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.1943 -16.9293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9096 -16.5183 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.4807 -16.5152 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.1872 -16.1039 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.4785 -20.2233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7649 -20.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7628 -21.4547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4753 -21.8712 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1917 -21.4601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1955 -20.6325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1415 -20.9539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7957 -20.9539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0505 -17.7457 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
11 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
18 20 1 0
18 21 1 0
17 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
3 26 1 0
26 27 1 0
26 31 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
28 32 1 0
32 33 1 0
33 30 1 0
1 34 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.88Molecular Weight (Monoisotopic): 515.1410AlogP: 4.46#Rotatable Bonds: 4Polar Surface Area: 45.25Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 5.85CX LogP: 4.60CX LogD: 4.58Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.55Np Likeness Score: -0.73
References 1. Cisar JS, Weber OD, Clapper JR, Blankman JL, Henry CL, Simon GM, Alexander JP, Jones TK, Ezekowitz RAB, O'Neill GP, Grice CA.. (2018) Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders., 61 (20): [PMID:30067909 ] [10.1021/acs.jmedchem.8b00951 ]